FDA Officially Bans Orange Dye From Hot Dog Casings
Published Date: 7/23/2026
Rule
Summary
The FDA is officially banning the use of the color additive Orange B on frankfurter and sausage casings because it’s no longer used or needed. This change affects food makers who color these meats and takes effect on September 8, 2026. If anyone disagrees, they have until August 24, 2026, to speak up—no extra costs or surprises, just a cleaner, clearer food color rule!
Analyzed Economic Effects
3 provisions identified: 1 benefits, 2 costs, 0 mixed.
Orange B Use Banned on Frankfurter Casings
If you make or color frankfurters or sausages, the FDA is revoking the rule that allowed Orange B to be used on casings or surfaces. The revocation takes effect September 8, 2026, and FDA says Orange B has not been batch certified for use in U.S. food since 1978.
Orange B Batch Certificates Terminate
All certificates for existing batches and portions of Orange B will cease to be effective for use in food on September 8, 2026. Any lot of Orange B will be regarded as uncertified after that date, and using Orange B in food after that date will make the food adulterated.
Deadline to Object or Request Hearing
If you will be adversely affected by this rule, you may file objections or request a hearing by August 24, 2026. Objections may be submitted electronically at https://www.regulations.gov or by written/paper submission following FDA instructions.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16296, Substances Generally Recognized as Safe
The Food and Drug Administration (FDA or we) is proposing to require the submission of generally recognized as safe (GRAS) notices for the use of a human or animal food substance purported to be GRAS under the conditions of its intended use under the Federal Food, Drug, and Cosmetic Act (FD&C Act).
2026-14073, Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign Establishments
The FDA wants to make it easier for drug makers who work in several locations to register as one company instead of many. They’re also updating rules for foreign drug companies to match new laws about handling health threats. If you’re in drug manufacturing, get ready to comment by September 11, 2026, and keep an eye on possible paperwork changes that could affect your business.
2026-13047, Establishment Registration and Product Listing for Tobacco Products
The FDA wants to make sure all tobacco product makers, both in the U.S. and abroad, register their businesses and list their products. This new rule closes a big gap by including foreign companies, helping the FDA keep better track of tobacco products for public health. Comments on this proposal are open until September 14, 2026, so affected businesses should get ready to update their info and possibly face new costs.
2025-04978, Nonprescription Drug Product With an Additional Condition for Nonprescription Use
The FDA is delaying a new rule about nonprescription drugs that have extra conditions for use. Originally set to start on March 21, 2025, the rule’s start date is now pushed back to May 27, 2025, to allow more time for review. This affects drug makers and consumers by giving everyone extra time to prepare for the new requirements without any immediate cost changes.
2025-01840, Nonprescription Drug Product With an Additional Condition for Nonprescription Use
The FDA’s new rule about nonprescription drugs needing extra conditions before use was set to start on January 27, 2025, but it’s now delayed until March 21, 2025. This delay follows a presidential order to pause and review new rules before they take effect. Drug makers, sellers, and consumers should note the new start date and get ready for the updated rules soon.
2026-20727, Medical Devices; Immunology and Microbiology Devices; Classification of the System for Detection of Nucleic Acid From Non-Viral Microorganism(s) Causing Sexually Transmitted Infections Using Home-Collected Specimens
The FDA is officially classifying home test kits that detect non-viral germs causing sexually transmitted infections as Class II devices, meaning they have special safety rules but fewer hurdles than the strictest category. This change, effective October 9, 2026, helps make these tests safer and easier to get, benefiting patients and innovators alike. If you make or use these home test kits, this update means better access and clear safety standards without extra costs or delays.
Previous / Next Documents
Previous: 2026-14895, Safety Zone; Lake St. Clair; New Baltimore, MI
The Coast Guard is setting up a new safety zone on Lake St. Clair near New Baltimore, Michigan to keep everyone safe during special events. This means boats will have to stay out of certain areas for a while, but no fees or big costs are involved. If you’re boating there, watch for the new rules starting soon!
Next: 2026-14934, Removal of Obsolete or Unnecessary Requirements
The Consumer Product Safety Commission is cleaning house by removing old and unnecessary rules that no longer matter. This update won’t change how safe products are but will make things simpler and cut down on extra costs for businesses. The new rules kick in on September 21, 2026, unless someone speaks up with a big objection by August 24, 2026.